Similar articles

• Interaction of 5,6- and 5,7-dihydroxytryptamine with tissue monoamine oxidase.

  Klemm HP, Baumgarten HG. Klemm HP, et al. Ann N Y Acad Sci. 1978 Jun 12;305:36-56. doi: 10.1111/j.1749-6632.1978.tb31509.x. Ann N Y Acad Sci. 1978. PMID: 280252 No abstract available.
• Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.

  Da Prada M, Pieri L, Keller HH, Pieri M, Bonetti EP. Da Prada M, et al. Ann N Y Acad Sci. 1978 Jun 12;305:595-620. doi: 10.1111/j.1749-6632.1978.tb31551.x. Ann N Y Acad Sci. 1978. PMID: 152083 No abstract available.
• Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.

  Björklund A, Baumgarten HG, Nobin A. Björklund A, et al. Adv Biochem Psychopharmacol. 1974;10:13-33. Adv Biochem Psychopharmacol. 1974. PMID: 4846535 No abstract available.
• Regeneration of serotonin neurons in the rat brain after 5,6-dihydroxytryptamine-induced axotomy.

  Wiklund L, Björklund A, Nobin A. Wiklund L, et al. Ann N Y Acad Sci. 1978 Jun 12;305:370-84. doi: 10.1111/j.1749-6632.1978.tb31534.x. Ann N Y Acad Sci. 1978. PMID: 360939 Review. No abstract available.
• Chemical neurotoxins as denervation tools in neurobiology.

  Jonsson G. Jonsson G. Annu Rev Neurosci. 1980;3:169-87. doi: 10.1146/annurev.ne.03.030180.001125. Annu Rev Neurosci. 1980. PMID: 6106449 Review. No abstract available.